WASATCH PHARMACEUTICAL INC
8-K, 1998-03-11
PHONOGRAPH RECORDS & PRERECORDED AUDIO TAPES & DISKS
Previous: FIRST UNION REAL ESTATE EQUITY & MORTGAGE INVESTMENTS, DEFC14A, 1998-03-11
Next: FORD MOTOR CO, S-8, 1998-03-11



                       SECURITIES AND EXCHANGE COMMISSION

                             Washington, D.C. 20549



                                    FORM 8-K



                                 CURRENT REPORT

     Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934


                         Date of Report: March 10, 1998



                          WASATCH PHARMACEUTICAL, INC.
              ----------------------------------------------------
             (Exact name of registrant as specified in its charter)

        UTAH                          000-22899                  84-0854009
- ----------------------------    ------------------------   --------------------
(State or other jurisdiction    (Commission File Number)   (IRS Employer ID No.)
 of incorporation)


                    714 East 7200 South, Midvale, Utah 84047
               ---------------------------------------------------
                     (Address of principal executive office)


Registrant's telephone number, including area code:   (801)  566-9688
                             
                                       N/A
    ------------------------------------------------------------------------
          (Former name or former address, if changed since last report)

<PAGE>


ITEM 2. ACQUISITION OR DISPOSITION OF ASSETS

Summary

         On February 23, 1998, Wasatch Pharmaceutical,  Inc., a Utah corporation
(the "Company"),  entered into an agreement (the  "Agreement")  with Mountaineer
Gas Transmission, Inc., a Nevada corporation,  registered to do business in West
Virginia ("Mountaineer"), wherein the Company exchanged its 25% working interest
in 50 gas wells located in Pleasants, Wood, and Ritchie Counties, West Virginia.
In connection with the exchange of the working  interest with  Mountaineer,  the
Company  received  1,800,000  shares of  restricted  common stock of the Company
which was returned to the treasury and canceled.

         The  Company  had  entered  into the  purchase  of  these 50 gas  wells
November 20, 1996 in an effort to enhance its cash flows. The cash flows did not
come as expected and the Company  determined  that an  investment in the oil and
gas  business  did not fit in with its long  term  strategy  of  setting  up and
operating medical skin care clinics.

<PAGE>

ITEM 7. FINANCIAL STATEMENTS, PRO FORMA FINANCIAL STATEMENTS, AND EXHIBITS

(b) (1)     Pro Forma Financial Statements

         The pro forma  financial  statements  required to be filed  pursuant to
this subsection will be supplied when available, but not later than 60 days from
the date of this filing.

(c) (1) Exhibits. The following exhibits are included as part of this report:

        SEC
Exhibit Reference
Number  Number     Title of Document                                  Location
- ------  ------     ---------------------------------------------     ----------
10.01     10       Agreement between Mountaineer Gas
                   Transmission, Inc. and Wasatch
                   Pharmaceutical, Inc., dated February 23, 1998     This filing




                                   SIGNATURES

         Pursuant to the requirements of the Securities Exchange Act of 1934, as
amended,  the  Registrant has duly caused this report to be signed on its behalf
by the undersigned hereunder duly authorized.

                                                WASATCH PHARMACEUTICAL, INC.


Date:   March 10, 1998                           /s/  David K. Giles
                                                 ------------------------------
                                                 David K. Giles, Secretary



                                    AGREEMENT


THIS AGREEMENT is made and entered into this 23rd day of February,  1998, by and
among  Mountaineer  Gas  Transmission,  Inc.,  whose address is 408 37th Street,
Parkersburg,  West  Virginia  26101,  hereinafter  referred to as ("MGT"),  and
Wasatch  Pharmaceutical,  Inc.,  whose address is 714 East 7200 South,  Midvale,
Utah 84047, hereinafter referred to as ("WASP").

                               W I T N E S S E T H

WHEREAS,  WASP is the owner of a  twenty-five  percent  interest  in certain gas
properties  located in West Virginia,  as shown in Exhibit A of this  agreement;
and,

WHEREAS,  MGT wishes to purchase the afore  mentioned gas properties with common
stock of WASP.

NOW THEREFORE the parties agree as follows.

1. MGT will provide  WASP with the  Assignments  for the  assignment of interest
of twenty-five percent of the working interest of the gas properties.

2. WASP will execute the  Assignments  (sign and notarize each  Assignment)  and
return the assignments to MGT via overnight courier.

3. Upon  receipt  of the  executed  assignments,  MGT will  forward  to WASP one
million eight hundred thousand shares of Wasatch Pharmaceutical,  Inc. issued to
International  Casualty  and  Surety  Co.,  Ltd.  As shown in  Exhibit B of this
agreement.  MGT will  deliver the shares  same day via  overnight  courier  upon
receipt of the executed Assignments.

By the execution and completion of this Agreement, Mountaineer Gas Transmission,
Inc. will forgive any costs associated with the operation of the afore mentioned
gas wells from the original purchase of the properties,  plus any past or future
liabilities, to the current date.

This is the entire agreement, any changes,  modifications, or amendments must be
made in writing, agree by both parties.

This  Agreement will be deemed to have been construed and delivered in the State
of West Virginia and governed by the laws of the State of West Virginia.

MOUNTAINEER GAS TRANSMISSION, INC.                WASATCH PHARMACEUTICAL, INC.



/s/  Tyghe Williams                                   /s/  Gary V. Heesch
- ----------------------------------                   ---------------------------
BY:   TYGHE WILLIAMS, PRESIDENT                   BY:   GARY V. HEESCH, CHAIRMAN



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission